Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2007 (Fycompa) dose-finding study in refractory partial seizures
NCT00416195Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2006
- Primary completion
- Feb 2008
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in partial epilepsy comparing E2007 with Placebo (2 arms). Primary endpoint: Percentage of Responders During the Maintenance Phase. Started Dec 2006; status: completed.
02
Drugs
perampanel
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT00416195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00416195.